Suppr超能文献

减毒活疫苗:历史上的成功与当前的挑战。

Live attenuated vaccines: Historical successes and current challenges.

作者信息

Minor Philip D

机构信息

National Institute of Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, United Kingdom.

出版信息

Virology. 2015 May;479-480:379-92. doi: 10.1016/j.virol.2015.03.032. Epub 2015 Apr 8.

Abstract

Live attenuated vaccines against human viral diseases have been amongst the most successful cost effective interventions in medical history. Smallpox was declared eradicated in 1980; poliomyelitis is nearing global eradication and measles has been controlled in most parts of the world. Vaccines function well for acute diseases such as these but chronic infections such as HIV are more challenging for reasons of both likely safety and probable efficacy. The derivation of the vaccines used has in general not been purely rational except in the sense that it has involved careful clinical trials of candidates and subsequent careful follow up in clinical use; the identification of the candidates is reviewed.

摘要

针对人类病毒性疾病的减毒活疫苗一直是医学史上最成功且具成本效益的干预措施之一。1980年宣布天花已被根除;脊髓灰质炎正接近全球根除,麻疹在世界大部分地区已得到控制。这类疫苗对诸如上述的急性疾病效果良好,但对于像艾滋病毒这样的慢性感染,鉴于可能的安全性和预期的有效性,更具挑战性。除了在对候选疫苗进行仔细的临床试验以及随后在临床使用中进行仔细的随访这一意义上,所用疫苗的研发总体上并非完全基于理性;本文对候选疫苗的识别进行了综述。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验